Learning objectives: Describe the impact of immunotherapies in treating relapsed/refractory diffuse large B cell lymphoma.
Discuss how immunotherapy response may be influenced by unique immune landscapes that exist among diffuse large B cell lymphomas.
05/30/2023 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Justin Kline, MD